| Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412 G Suntharalingam, MR Perry, S Ward, SJ Brett, A Castello-Cortes, ... New England Journal of Medicine 355 (10), 1018-1028, 2006 | 2627 | 2006 |
| Stem cell bioprocessing: fundamentals and principles MR Placzek, IM Chung, HM Macedo, S Ismail, T Mortera Blanco, M Lim, ... Journal of the Royal Society interface 6 (32), 209-232, 2009 | 257 | 2009 |
| Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC … GJ Morgan, FE Davies, WM Gregory, SE Bell, AJ Szubert, NN Coy, ... Haematologica 97 (3), 442-450, 2012 | 217 | 2012 |
| Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide CN Harrison, AJ Mead, A Panchal, S Fox, C Yap, E Gbandi, A Houlton, ... Blood, The Journal of the American Society of Hematology 130 (17), 1889-1897, 2017 | 174 | 2017 |
| Localization of androgen receptor expression in human bone marrow A Mantalaris, N Panoskaltsis, Y Sakai, P Bourne, C Chang, EM Messing, ... The Journal of pathology 193 (3), 361-366, 2001 | 171 | 2001 |
| Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial GJ Morgan, FE Davies, WM Gregory, AJ Szubert, SE Bell, MT Drayson, ... Blood 119 (23), 5374-5383, 2012 | 161 | 2012 |
| The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial AK Burnett, D Milligan, A Goldstone, A Prentice, MF McMullin, M Dennis, ... British Journal of Haematology 145 (3), 318-332, 2009 | 159 | 2009 |
| The development of a three-dimensional scaffold for ex vivo biomimicry of human acute myeloid leukaemia TM Blanco, A Mantalaris, A Bismarck, N Panoskaltsis Biomaterials 31 (8), 2243-2251, 2010 | 113 | 2010 |
| Long-term cytokine-free expansion of cord blood mononuclear cells in three-dimensional scaffolds T Mortera-Blanco, A Mantalaris, A Bismarck, N Aqel, N Panoskaltsis Biomaterials 32 (35), 9263-9270, 2011 | 107 | 2011 |
| Engineering a mimicry of bone marrow tissue ex vivo N Panoskaltsis, A Mantalaris, JHD Wu Journal of bioscience and bioengineering 100 (1), 28-35, 2005 | 107 | 2005 |
| Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia N Panoskaltsis, CDL Reid, SC Knight Leukemia 17 (4), 716-730, 2003 | 103 | 2003 |
| Intelligent bioprocessing for haemotopoietic cell cultures using monitoring and design of experiments M Lim, H Ye, N Panoskaltsis, EM Drakakis, X Yue, AEG Cass, ... Biotechnology advances 25 (4), 353-368, 2007 | 90 | 2007 |
| Oxidized alginate hydrogels with the GHK peptide enhance cord blood mesenchymal stem cell osteogenesis: A paradigm for metabolomics-based evaluation of biomaterial design ME Klontzas, S Reakasame, R Silva, JCF Morais, S Vernardis, ... Acta biomaterialia 88, 224-240, 2019 | 72 | 2019 |
| Human embryonic and induced pluripotent stem cells maintain phenotype but alter their metabolism after exposure to ROCK inhibitor SI Vernardis, K Terzoudis, N Panoskaltsis, A Mantalaris Scientific reports 7 (1), 42138, 2017 | 62 | 2017 |
| Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia M Dennis, N Russell, RK Hills, C Hemmaway, N Panoskaltsis, ... Blood, The Journal of the American Society of Hematology 125 (19), 2923-2932, 2015 | 58 | 2015 |
| Modeling and analysis of individualized pharmacokinetics and pharmacodynamics for volatile anesthesia A Krieger, N Panoskaltsis, A Mantalaris, MC Georgiadis, EN Pistikopoulos IEEE Transactions on Biomedical Engineering 61 (1), 25-34, 2013 | 42 | 2013 |
| A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemia AK Burnett, N Russell, RK Hills, N Panoskaltsis, A Khwaja, C Hemmaway, ... Leukemia 29 (6), 1312-1319, 2015 | 39 | 2015 |
| Towards unravelling the kinetics of an acute myeloid leukaemia model system under oxidative and starvation stress: a comparison between two-and three-dimensional cultures EG Velliou, SB Dos Santos, MM Papathanasiou, M Fuentes-Gari, ... Bioprocess and biosystems engineering 38, 1589-1600, 2015 | 38 | 2015 |
| Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib AE Perl, N Hosono, P Montesinos, N Podoltsev, G Martinelli, ... Blood cancer journal 12 (5), 84, 2022 | 37 | 2022 |
| Optimization of CAR T-cell therapies supply chains P Karakostas, N Panoskaltsis, A Mantalaris, MC Georgiadis Computers & Chemical Engineering 139, 106913, 2020 | 36 | 2020 |
